Tariffs will trigger some job losses, and impact future investment, but Ireland’s strategic value remains solid - ‘Pharma isn ...

EUROPE needs to take on the US in a tit-for-tat tariff war to push back against Donald Trump’s bullying, the leader of ...

While much progress has been made to improve the health of millions of people, more work is required to achieve health and ...

America's industrial base is not collapsing. It's evolving—becoming more productive, more specialized, and more ...

How innovation, advanced manufacturing, and expertise drive success in the evolving CDMO and generics landscape.

Concerns about potential pharma tariffs began before Trump took office after he repeatedly threatened a 25% tariff.

Over a month into Robert F. Kennedy Jr.’s tenure as HHS Secretary, leaders in pharma, medical marketing and media circles are preparing for a potential TV pharma ad ban.

GSK remains on fairly stable financial footing, with a debt/EBITDA ratio of 2.8 at the end of 2024 and Haleon taking on close to GBP 10 billion of GSK's debt in the 2022 divestment. With the improving ...

Novo Nordisk shares have fallen 25% so far in March and are on track for their biggest monthly drop since July 2002, as ...

Not all corners of the market are moving in the same direction this year; 2025 has already delivered a few surprises for sector-focused investors ...

Years after the biopharmaceutical industry stepped up to create COVID-19 vaccines as the virus spiraled into global pandemic, ...